Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022
复制标题
DOI：
10.1101/2021.12.10.21267408v3
复制
发表时间：
2022-03-18
影响因子：
33.9
通讯作者：
Gaglani, Manjusha
中科院分区：
文献类型：
--
作者：
Fowlkes, Ashley L.;Yoon, Sarang K.;Gaglani, Manjusha
事实证明，接受 2 剂辉瑞 BioNTech COVID-19 疫苗可有效预防 SARS-CoV-2 B.1.617 感染。 2 (Delta) 变异发生在年龄 ≥ 12 岁的人群中。
Receipt of 2 doses of Pfizer-BioNTech COVID-19 vaccine has been shown to be effective in preventing infection with the SARS-CoV-2 B. 1.617. 2 (Delta) variant in persons aged≥ 12 years.